Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown 2193, South Africa.
Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown 2193, South Africa.
Int J Pharm. 2017 Oct 30;532(1):90-104. doi: 10.1016/j.ijpharm.2017.08.109. Epub 2017 Aug 30.
This study was conducted to provide a mechanistic account for understanding the synthesis, characterization and solubility phenomena of vitamin complexes with cyclodextrins (CD) for enhanced solubility and stability employing experimental and in silico molecular modeling strategies. New geometric, molecular and energetic analyses were pursued to explicate experimentally derived cholecalciferol complexes. Various CD molecules (α-, β-, γ-, and hydroxypropyl β-) were complexed with three vitamins: cholecalciferol, ascorbic acid and α-tocopherol. The Inclusion Efficiency (IE%) was computed for each CD-vitamin complex. The highest IE% achieved for a cholecalciferol complex was for 'βCDD-8', after utilizing a unique CD:cholecalciferol molar synthesis ratio of 2.5:1, never before reported as successful. 2HPβCD-cholecalciferol, γCD-cholecalciferol and α-tocopherol inclusion complexes (IC's) reached maximal IE% with a CD:vitamin molar ratio of 5:1. The results demonstrate that IE%, thermal stability, concentration, carrier solubility, molecular mechanics and intended release profile are key factors to consider when synthesizing vitamin-CD complexes. Phase-solubility data provided insights into the design of formulations with IC's that may provide analogous oral vitamin release profiles even when hydrophobic and hydrophilic vitamins are co-incorporated. Static lattice atomistic simulations were able to validate experimentally derived cholecalciferol IE phenomena and are invaluable parameters when approaching formulation strategies using CD's for improved solubility and efficacy of vitamins.
本研究旨在通过实验和计算分子建模策略,提供一种理解维生素与环糊精(CD)合成、表征和溶解现象的机制解释,以提高维生素的溶解度和稳定性。我们进行了新的几何、分子和能量分析,以阐明实验得出的胆钙化醇配合物。研究了三种维生素(胆钙化醇、抗坏血酸和α-生育酚)与不同的 CD 分子(α-、β-、γ-和羟丙基-β-CD)形成复合物。计算了每个 CD-维生素复合物的包合效率(IE%)。利用独特的 CD:胆钙化醇摩尔合成比 2.5:1,成功合成了胆钙化醇配合物“βCDD-8”,其 IE%最高,这是以前从未报道过的。2HPβCD-胆钙化醇、γCD-胆钙化醇和α-生育酚包合物(IC)在 CD:维生素摩尔比为 5:1 时达到最大 IE%。结果表明,IE%、热稳定性、浓度、载体溶解度、分子力学和预期释放特性是合成维生素-CD 配合物时需要考虑的关键因素。相溶解度数据为设计包含 IC 的配方提供了深入了解,即使同时包含疏水性和亲水性维生素,IC 也可能提供类似的口服维生素释放特性。静态晶格原子模拟能够验证实验得出的胆钙化醇 IE 现象,对于使用 CD 提高维生素溶解度和功效的配方策略,是非常有价值的参数。